Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies (Tables)

v3.20.4
Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2020
Accounting Policies [Abstract]  
Schedule of Marketable Securities
   

Quoted Prices in Active

Markets for Identical Assets

or Liabilities
(Level 1)

    

Quoted Prices for

Similar Assets or

Liabilities in

Active Markets
(Level 2)

    

Significant

Unobservable
Inputs
(Level 3)

  
Marketable securities at December 31, 2020   $ 16,718,452     $ -     $ -  
                         
Marketable securities at December 31, 2019   $ 9,164,273     $ -     $ -  

Schedule of Estimated Useful Life of Property Plant and Equipment
    The estimated useful lives for the current and comparative periods are as follows:

 

    Useful Life
    (in years)
Plant and equipment   5-12
Furniture and fixtures   5-10
Computer equipment & software   3-5
Leasehold Improvements   Shorter of the
remaining lease or
estimated useful life

Schedule of Estimated Useful Life of Other Intangible Assets

The estimated useful lives for the current and comparative periods are as follows:

 

      Useful Life  
      (in years)  
Patents and trademarks     12-17  

Schedule of Other Information Related to Leases

Other information related to leases is presented below:

  

Other information   As of
December 31, 2020		  
       
Operating cash used by operating leases   $ 151,640  
Weighted-average remaining lease term – operating leases (in months)     -  
Weighted-average discount rate – operating leases     10 %

Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share

The following securities are excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

 

    For the Years Ended December 31,  
    2020     2019  
Stock Options     -       40  
Restricted Stock Units     789,360       15,603  
Warrants to purchase Common Stock     10,925,952       247,215  
Pre-funded Warrants to purchase Common Stock     1,040,540       795,000  
Warrants to purchase Series C Preferred Stock     55,000       1,990,000  
Series D Convertible Preferred Stock     72,992       -  
Total potentially dilutive shares     12,883,844       3,047,858